RDHL
Price
$1.93
Change
+$0.01 (+0.52%)
Updated
Jun 5, 04:54 PM (EDT)
Capitalization
15.74M
70 days until earnings call
SBFM
Price
$1.50
Change
-$0.01 (-0.66%)
Updated
Jun 5, 04:49 PM (EDT)
Capitalization
6.02M
55 days until earnings call
Interact to see
Advertisement

RDHL vs SBFM

Header iconRDHL vs SBFM Comparison
Open Charts RDHL vs SBFMBanner chart's image
Redhill Biopharma
Price$1.93
Change+$0.01 (+0.52%)
Volume$200
Capitalization15.74M
Sunshine Biopharma
Price$1.50
Change-$0.01 (-0.66%)
Volume$730
Capitalization6.02M
RDHL vs SBFM Comparison Chart
Loading...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RDHL vs. SBFM commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDHL is a StrongBuy and SBFM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (RDHL: $1.93 vs. SBFM: $1.48)
Brand notoriety: RDHL and SBFM are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RDHL: 5% vs. SBFM: 3%
Market capitalization -- RDHL: $15.74M vs. SBFM: $6.02M
RDHL [@Pharmaceuticals: Other] is valued at $15.74M. SBFM’s [@Pharmaceuticals: Other] market capitalization is $6.02M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RDHL’s FA Score shows that 0 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • RDHL’s FA Score: 0 green, 5 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, SBFM is a better buy in the long-term than RDHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RDHL’s TA Score shows that 5 TA indicator(s) are bullish while SBFM’s TA Score has 3 bullish TA indicator(s).

  • RDHL’s TA Score: 5 bullish, 2 bearish.
  • SBFM’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, RDHL is a better buy in the short-term than SBFM.

Price Growth

RDHL (@Pharmaceuticals: Other) experienced а +9.66% price change this week, while SBFM (@Pharmaceuticals: Other) price change was +2.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.45%. For the same industry, the average monthly price growth was +14.82%, and the average quarterly price growth was +63.61%.

Reported Earning Dates

RDHL is expected to report earnings on Aug 14, 2025.

SBFM is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDHL($15.7M) has a higher market cap than SBFM($6.02M). SBFM YTD gains are higher at: -49.667 vs. RDHL (-69.082). RDHL has higher annual earnings (EBITDA): 52.8M vs. SBFM (-26.1M). SBFM has more cash in the bank: 18.8M vs. RDHL (7.01M). SBFM has less debt than RDHL: SBFM (674K) vs RDHL (2.28M). RDHL has higher revenues than SBFM: RDHL (35.7M) vs SBFM (20.4M).
RDHLSBFMRDHL / SBFM
Capitalization15.7M6.02M261%
EBITDA52.8M-26.1M-202%
Gain YTD-69.082-49.667139%
P/E RatioN/A0.88-
Revenue35.7M20.4M175%
Total Cash7.01M18.8M37%
Total Debt2.28M674K339%
FUNDAMENTALS RATINGS
RDHL vs SBFM: Fundamental Ratings
RDHL
SBFM
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
9565
P/E GROWTH RATING
1..100
8086
SEASONALITY SCORE
1..100
5024

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (38) in the null industry is somewhat better than the same rating for RDHL (86) in the Biotechnology industry. This means that SBFM’s stock grew somewhat faster than RDHL’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as RDHL (100) in the Biotechnology industry. This means that SBFM’s stock grew similarly to RDHL’s over the last 12 months.

SBFM's SMR Rating (92) in the null industry is in the same range as RDHL (100) in the Biotechnology industry. This means that SBFM’s stock grew similarly to RDHL’s over the last 12 months.

SBFM's Price Growth Rating (65) in the null industry is in the same range as RDHL (95) in the Biotechnology industry. This means that SBFM’s stock grew similarly to RDHL’s over the last 12 months.

RDHL's P/E Growth Rating (80) in the Biotechnology industry is in the same range as SBFM (86) in the null industry. This means that RDHL’s stock grew similarly to SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RDHLSBFM
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 23 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DXC15.450.38
+2.52%
DXC Technology Company
TOST41.840.21
+0.50%
Toast
MBIO1.29N/A
N/A
Mustang Bio Inc
UWMC4.12N/A
N/A
UWM Holdings Corp
IKT1.98-0.05
-2.46%
Inhibikase Therapeutics

RDHL and

Correlation & Price change

A.I.dvisor tells us that RDHL and ACET have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDHL and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDHL
1D Price
Change %
RDHL100%
+3.23%
ACET - RDHL
27%
Poorly correlated
+1.54%
EOLS - RDHL
27%
Poorly correlated
-1.61%
SNOA - RDHL
23%
Poorly correlated
-4.23%
DVAX - RDHL
23%
Poorly correlated
-1.20%
TEVA - RDHL
22%
Poorly correlated
+1.92%
More

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and TXMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and TXMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-2.58%
TXMD - SBFM
22%
Poorly correlated
+4.63%
EVOK - SBFM
22%
Poorly correlated
-2.91%
SUPN - SBFM
22%
Poorly correlated
+0.22%
SIGA - SBFM
21%
Poorly correlated
-0.81%
RDHL - SBFM
21%
Poorly correlated
+3.23%
More